Cognex Corp (CGNX) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts CGNX Hot Sheet
Price: $62.25 +2.40%
EPS Growth %: +57.6%
Financial Fact:
Research, development, and engineering expenses: 18.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +57.6%
Financial Fact:
Research, development, and engineering expenses: 18.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cognex Corp (NASDAQ: CGNX) reported Q2 EPS of $0.32, $0.06 better than the analyst estimate of $0.26. Revenue for the quarter came in at $242.51 million versus the consensus estimate of $237.76 million.
For earnings history and earnings-related data on Cognex Corp (CGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
